A comprehensive surveillance study on the patients with malignant lymphoma undergoing CODOX-M/IVAC regimen with or without rituximab.
Not Applicable
Recruiting
- Conditions
- Malignant lymphoma
- Registration Number
- JPRN-UMIN000024841
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have a communication problem in Japanese. 2)Patients who are disqualified by their attending physician. 3)In the case of questionnaire investigation, patients undergoing second-line therapy except for additional radiation therapy for residual lesion after CODOX-M/IVAC with or without rituximab.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of fertility
- Secondary Outcome Measures
Name Time Method Pregnancy among the patients with fertility preservation, Quality of life (SF-36), Social rehabilitation, Complications, Long-term prognostic analysis